Newron Pharmaceuticals S.p.A.

Director's Dealing • Apr 24, 2025

News Details

Directors’ Dealings | 24 April 2025 16:22

Newron Pharmaceuticals S.p.A.: Tuula Martin, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

24.04.2025 / 16:21 CET/CEST

The issuer is solely responsible for the content of this announcement.

---

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name:	Tuula
Last name(s):	Martin

2. Reason for the notification

a) Position / status

Person closely associated with:
Title:	Dr.
First name:	Chris
Last name(s):	Martin
Position:	Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Newron Pharmaceuticals S.p.A.

b) LEI

8156002F8C11F80A9740

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	IT0004147952

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s)	Volume(s)
7.296 CHF	5,472.00 CHF

d) Aggregated information

Price	Aggregated volume
7.2960 CHF	5,472.0000 CHF

e) Date of the transaction

23/04/2025; UTC+2

f) Place of the transaction

Name:	SIX Swiss Exchange
MIC:	XSWX

---

24.04.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---

Language:	English
Company:	Newron Pharmaceuticals S.p.A.
	via Antonio Meucci 3
	20091 Bresso
	Italy
Internet:	www.newron.com

End of News	EQS News Service

---

98304  24.04.2025 CET/CEST